Alexandre Bazinet

25PUBLICATIONS

102CO-AUTHORS

Gene and molecular therapyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 11, 2026

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|May 17, 2026

Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL.

|Apr 26, 2026

Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Mar 28, 2026

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Alexandre Bazinet, Alex Bataller, Kelly Chien

|Mar 12, 2026

Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

|Mar 06, 2026

Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasms.

Kelly S Chien, Ziyi Li, Luca Lanino

Pageof 5

Frequent Collaborators

21 joint publications

Tapan M Kadia

19 joint publications

Courtney DiNardo

18 joint publications

Farhad Ravandi

18 joint publications

Hagop M Kantarjian

17 joint publications

Elias Jabbour

17 joint publications

Naval G Daver

17 joint publications

Guillermo Garcia-Manero

16 joint publications

Alex Bataller

15 joint publications

Nicholas Short

15 joint publications

Gautam Borthakur

Frequent Collaborators

21 joint publications

Tapan M Kadia

19 joint publications

Courtney DiNardo

18 joint publications

Farhad Ravandi

18 joint publications

Hagop M Kantarjian